AI assistant
Sending…
Sunshine Biopharma Inc. — Director's Dealing 2022
Jun 6, 2022
35352_dirs_2022-06-06_e609f627-4548-457f-91db-2e934dcf2133.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sunshine Biopharma, Inc (SBFM)
CIK: 0001402328
Period of Report: 2022-06-03
Reporting Person: Sebaaly Camille (CFO/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-03 | Common Stock | P | 25000 | $1.22 | Acquired | 144465 | Direct |
More from Sunshine Biopharma Inc.
Share Issue/Capital Change
2026
May 29
Capital/Financing Update
2026
May 19
Share Issue/Capital Change
2026
May 19
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Apr 9
Annual Report
2026
Apr 3
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 20
Board/Management Information
2026
Feb 5
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 12
Interim / Quarterly Report
2025
Nov 13